Literature DB >> 29735496

Glucosuria without diabetes: key to the diagnosis of fragility fractures due to Fanconi syndrome.

Lilluck F Alacapa1, Mark Anthony Santiago Sandoval1,2, Coralie Therese D Dimacali3, Nathaniel Jr S Orillaza4.   

Abstract

A 64-year-old woman had fragility fractures which caused her to have gross deformities and confined her to bed. These were initially ascribed to vitamin D deficiency. However, despite correction of the deficiency, she did not improve. A review of previous records already showed glucosuria in the absence of diabetes, but this finding was overlooked. Eight years into the disease, it was realised that the glucosuria despite normal blood sugar could also mean that the patient was losing other substances needed for proper bone formation. Further investigations showed hypophosphataemia, renal phosphate wasting, hypokalaemia, mild metabolic acidosis, alkaline urine pH, hypouricaemia and aminoaciduria, all compatible with a proximal renal tubular defect (Fanconi syndrome). The fragility fractures were due to poor bone mineralisation because of hypophosphataemia induced by the inability of the kidneys to conserve phosphorus. © BMJ Publishing Group Ltd (unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  calcium and bone; fluid electrolyte and acid-base disturbances; orthopaedics; renal medicine

Mesh:

Substances:

Year:  2018        PMID: 29735496      PMCID: PMC5950564          DOI: 10.1136/bcr-2017-223350

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  7 in total

1.  [Glycosuric osteopathy: so-called Fanconi syndrome in adults].

Authors:  F KUHLENCORDT
Journal:  Ergeb Inn Med Kinderheilkd       Date:  1958

2.  Hypophosphataemic glycosuric rickets (Fanconi syndrome).

Authors:  G C LINDER; G M BULL
Journal:  Clin Proc       Date:  1949-03

Review 3.  Renal tubular reabsorption of phosphate (TmP/GFR): indications and interpretation.

Authors:  R B Payne
Journal:  Ann Clin Biochem       Date:  1998-03       Impact factor: 2.057

Review 4.  Chromium.

Authors:  D G Barceloux
Journal:  J Toxicol Clin Toxicol       Date:  1999

Review 5.  Adult Fanconi syndrome secondary to light chain gammopathy. Clinicopathologic heterogeneity and unusual features in 11 patients.

Authors:  T Messiaen; S Deret; B Mougenot; F Bridoux; P Dequiedt; J J Dion; R Makdassi; F Meeus; J Pourrat; G Touchard; P Vanhille; P Zaoui; P Aucouturier; P M Ronco
Journal:  Medicine (Baltimore)       Date:  2000-05       Impact factor: 1.889

6.  Hypophosphatemic osteomalacia and adult Fanconi syndrome due to light-chain nephropathy. Another form of oncogenous osteomalacia.

Authors:  D S Rao; A M Parfitt; A R Villanueva; P J Dorman; M Kleerekoper
Journal:  Am J Med       Date:  1987-02       Impact factor: 4.965

Review 7.  Drug-induced renal Fanconi syndrome.

Authors:  A M Hall; P Bass; R J Unwin
Journal:  QJM       Date:  2013-12-24
  7 in total
  1 in total

1.  Canagliflozin, an SGLT2 inhibitor, corrects glycemic dysregulation in TallyHO model of T2D but only partially prevents bone deficits.

Authors:  Kathryn M Thrailkill; R Clay Bunn; Sasidhar Uppuganti; Philip Ray; Iuliana Popescu; Evangelia Kalaitzoglou; John L Fowlkes; Jeffry S Nyman
Journal:  Bone       Date:  2020-09-02       Impact factor: 4.398

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.